NSF Reorganization Spawns Social Science Directorate

WASHINGTON--The National Science Foundation has reshuffled its grant-making bureaucracy to give greater prominence to the social and behavioral sciences. The reorganization, announced earlier this month by NSF director Walter Massey, also addresses simmering problems within the foundation's policy analysis and survey research programs that have led to congressional inquiries and heated debate within the field. The new NSF organizational chart, as described by Massey during a meeting of its gov

Written byJeffrey Mervis
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

The new NSF organizational chart, as described by Massey during a meeting of its governing body, the National Science Board, features:

* A new directorate, one of six serving research scientists, that will cover the social, behavioral, and economic sciences (SBES). The agency has launched a national search for an eminent social scientist to run the new entity, which was carved from the directorate for biological, behavioral, and social sciences (BBS);

* The pared-down BBS directorate, renamed biological sciences (BS), roughly three-quarters of its former size. It will continue to be headed by microbiologist Mary Clutter.

* The elimination of the directorate for scientific, technological, and international affairs (STIA), which is now served by an acting head. Its international programs and science resources studies (SRS) divisions will be moved to SBES, and its division of policy and research analysis (PRA) will become part of a new office of planning and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies